Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

*If you are interested in becoming a part of our OBN Spotlight TV series, reach us at info@ophthalmologybreakingnews.com. Q1: As you reflect on the recent ESCRS 2023 Congress, could you share with us the key highlights and breakthroughs in cataract…

New World Medical announced a significant milestone with the receipt of 510(k) indication expansion from the U.S. Food and Drug Administration (FDA) for KDB (Kahook Dual Blade) GLIDE. This clearance allows for the reduction of intraocular pressure (IOP) in adult…

Researchers at the University of East Anglia (UEA) have developed a novel resin suitable for 3D printing intraocular devices. This pioneering innovation holds the potential to revolutionize the production of eye implants, which are crucial for cataract and refractive surgeries,…

Glenmark Pharmaceuticals has received final approval by the FDA for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% for glaucoma treatment. This solution has been recognized by the FDA as bioequivalent and therapeutically equivalent to Combigan® Ophthalmic Solution, 0.2%|0.5% by…

ArcScan, a global medical technology company dedicated to revolutionizing ophthalmic care, marked a significant milestone with the announcement of the National Medical Products Administration (NMPA) approval of its flagship product, the ArcScan Insight® 100, for use in China. Addressing the…

Humonix Biosciences, a pioneering biotechnology company, has recently named Dr. Karen Torrejon as its new Chief Executive Officer. Dr. Torrejon, who originally founded the company in 2014, will now lead its operations as it transitions into a broader, science-driven platform.…

Researchers have developed a prototype “smart” contact lens that accurately measures eye pressure regardless of temperature, according to a study in ACS Applied Materials & Interfaces. Around 3 million people in the U.S. suffer from glaucoma, according to the Centers…

Oculis has completed enrollment in its multicenter, randomized, double-blind, placebo-controlled phase 2 ACUITY trial evaluating the safety and tolerability of OCS-05 in patients with Acute Optic Neuritis (AON). Topline results are expected in Q4 2024. The phase 2 ACUITY study…

Staar Surgical announced a strategic partnership with IQ Laser Vision, a prominent vision correction organization with locations throughout California and Texas. This collaboration aims to significantly increase the use of EVO ICL lenses for surgical vision correction, specifically targeting patients…

Myopia, or short-sightedness, is one of the most common eye health issues in children and means that they can’t see objects that are far away, causing their vision to blur. Symptoms usually appear between the ages of 8 and 12…